VIDEO: Euretina best free paper award winner speaks on analysis of HAWK, HARRIER data

ByArshad Khanani, MD, MA, FASRS

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this video, Arshad Khanani, MD, speaks about a post hoc comparative assessment of patients treated with brolucizumab vs. aflibercept in the HAWK and HARRIER phase 3 studies.

For his presentation on this topic, Khanani received the best free paper award at the virtual Euretina congress.

Published by:

Sources/Disclosures

Collapse

Source:

Arshad Khanani, MD

Read more about

aflibercept

brolucizumab

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment